Cellular and antibody responses directed against the HIV-1 principal neutralizing domain in HIV-1-infected children.
暂无分享,去创建一个
[1] A. Casadevall,et al. Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans , 1992, The Lancet.
[2] K. Cease,et al. Priming with T helper cell epitope peptides enhances the antibody response to the envelope glycoprotein of HIV-1 in primates. , 1991, Journal of immunology.
[3] A. Profy,et al. Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1 , 1990, Science.
[4] J. Davide,et al. Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. , 1990, Science.
[5] J. Ambrus,et al. Divergent activities of protein kinases in IL-6-induced differentiation of a human B cell line. , 1990, Journal of immunology.
[6] A. Rubinstein,et al. Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[7] W. Blattner,et al. C-terminal fragments of gp120 and synthetic peptides from five HTLV-III strains: prevalence of antibodies to the HTLV-III-MN isolate in infected individuals. , 1990, AIDS research and human retroviruses.
[8] J. Berzofsky,et al. A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160. , 1989, Science.
[9] R. Laskov,et al. The role of somatic hypermutation in the generation of antibody diversity. , 1989, Science.
[10] J. Berzofsky,et al. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals , 1989, Nature.
[11] K. Steimer,et al. Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro. , 1989, The Journal of clinical investigation.
[12] D. Richman,et al. T cell recognition of HIV synthetic peptides in a natural infection. , 1989, Journal of immunology.
[13] K. Cease,et al. Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans , 1988, Nature.
[14] J. Blomberg,et al. Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[15] C. Debouck,et al. Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[16] L. Arthur,et al. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[17] J. Margolick,et al. Functional and biochemical characterization of B-cell differentiation factor (BCDF) produced by an HTLV-I-transformed human T-cell clone and demonstration of specific binding of the factor to a BCDF responsive cell line. , 1987, Cellular immunology.
[18] R. M. Khaitov,et al. Immunology of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. An update. , 1987, Annals of internal medicine.
[19] R. Kurth,et al. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection , 1987, Journal of virology.
[20] T. Waldmann,et al. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. , 1985, The New England journal of medicine.
[21] A. Fauci,et al. Characterization of a T4+/Leu-8+ T cell clone that directly helps B cell Ig production by secreting B cell differentiation factor. , 1985, Journal of immunology.
[22] Kendall A. Smith,et al. T cell growth factor: parameters of production and a quantitative microassay for activity. , 1978, Journal of immunology.
[23] T. Merigan,et al. Recombinant HIV structural proteins detect specific cellular immunity in vitro in infected individuals. , 1988, AIDS research and human retroviruses.
[24] M. Borzy. Interleukin 2 production and responsiveness in individuals with acquired immunodeficiency syndrome and the generalized lymphadenopathy syndrome. , 1987, Cellular immunology.